Coeptis Therapeutics Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Coeptis Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2021.
  • Coeptis Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $1.13M, a 54.7% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $8.22M, a 183% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $8.22M +$5.32M +183% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-11
2020 $2.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.